Champions Oncology Stock Statistic Functions Beta
| CSBR Stock | USD 4.55 0.28 6.56% |
| Symbol |
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Champions Oncology correlated with the market. If Beta is less than 0 Champions Oncology generally moves in the opposite direction as compared to the market. If Champions Oncology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Champions Oncology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Champions Oncology is generally in the same direction as the market. If Beta > 1 Champions Oncology moves generally in the same direction as, but more than the movement of the benchmark.
Champions Oncology Technical Analysis Modules
Most technical analysis of Champions Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Champions from various momentum indicators to cycle indicators. When you analyze Champions charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Champions Oncology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Champions Oncology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Champions Oncology based on widely used predictive technical indicators. In general, we focus on analyzing Champions Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Champions Oncology's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Champions Oncology's intrinsic value. In addition to deriving basic predictive indicators for Champions Oncology, we also check how macroeconomic factors affect Champions Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Dividend Yield | 0.003734 | 0.003319 | Price To Sales Ratio | 1.31 | 1.24 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Champions Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Champions Oncology's short interest history, or implied volatility extrapolated from Champions Oncology options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Casinos Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Impulse Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | FinTech Invested over 40 shares | |
 | Artificial Intelligence Invested few shares | |
 | Cash Cows Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Momentum Invested over 60 shares | |
Additional Tools for Champions Stock Analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.